News
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...
Results come after positive results from a trial among people with idiopathic pulmomary disease.
22h
Capital Market on MSNLupin launches generic version of anticholinergic medication Ipratropium bromide in United StatesIpratropium Bromide Nasal Solution is a bioequivalent to Atrovent Nasal Sprayof Boehringer Ingelheim Pharmaceuticals, Inc.
The avian metapneumovirus treatment market value is expected to be approximately USD 311.6 million, which is anticipated to nearly double, reaching around USD 579.5 million by 2035. This market is ...
The first half of 2025 has been marked by a surge in strategic activity across the global healthcare, life sciences, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results